Madrigal Pharmaceuticals Announces Three New Resmetirom Patents, Strengthening IP Portfolio

Go back to Madrigal Pharmaceuticals Announces Three New Resmetirom Patents, Strengthening IP Portfolio
(NASDAQ: MDGL) Delayed: 543.35 +5.70 (1.06%)
Previous Close $537.65    52 Week High $18.24 
Open $537.65    52 Week Low $6.60 
Day High $549.04    P/E N/A 
Day Low $526.61    EPS $0.00 
Volume 160,513